Press release
Neuropathic Pain Market Size, Share & Forecast | 2024-2031 | Trends Companies likes - Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company., Vertex Pharmaceuticals
Neuropathic Pain Market
Neuropathic Pain Market is comprehensively covered in the DataM Intelligence report, which offers critical data, industry trends, and market intelligence. The study delves into the competitive environment, assessing leading players on their product portfolios, pricing, financial health, strategic growth initiatives, and geographic expansion.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/neuropathic-pain-market?ca
Neuropathic pain is a chronic pain condition caused by damage or dysfunction in the nervous system, leading to sensations like burning, tingling, or shooting pain. It can result from conditions such as diabetes, shingles, spinal cord injuries, or nerve trauma, and is often managed with medications like anticonvulsants, antidepressants, and topical agents, alongside physical and psychological therapies.
Major players in the Neuropathic Pain market
The prominent players in Neuropathic Pain market research report are: Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company., Vertex Pharmaceuticals, Abbott, Medtronic, Nevro Corp., Grünenthal, Teva Pharmaceuticals Inc., and Sun Pharmaceutical Industries Ltd.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Neuropathic Pain Market Key Development
→ In November 2024, Grünenthal's U.S. subsidiary, Averitas Pharma, completed recruitment for the Phase III AV001 trial evaluating QUTENZA (capsaicin) 8% patch for post-surgical neuropathic pain. Positive results could support a label expansion in the U.S.
→ In January 2023, Neuralace Medical received FDA clearance for Axon Therapy, the first non-invasive magnetic peripheral nerve stimulation (mPNS) approved for chronic painful diabetic neuropathy, offering a new pain relief option.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/neuropathic-pain-market?ca
Neuropathic Pain Market Segments
By Type: Diabetic Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Post-Herpetic Neuralgia, Trigeminal Neuralgia, Spinal Stenosis, Others
By Treatment Type: Drug Class, Devices
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The Neuropathic Pain industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Neuropathic Pain Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market Size, Share & Forecast | 2024-2031 | Trends Companies likes - Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company., Vertex Pharmaceuticals here
News-ID: 4017317 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Rheumatoid Arthritis Drugs Market to Reach US$ 56.62 Billion by 2033 at 6.8% CAG …
According to DataM Intelligence, the global rheumatoid arthritis (RA) drugs market reached US$ 31.27 billion in 2024 and is expected to reach US$ 56.62 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033. Market growth is supported by the rising prevalence of rheumatoid arthritis, increasing adoption of biologics and targeted therapies, early diagnosis, and expanding access to advanced treatment options across developed and emerging healthcare…
Antibody-Drug Conjugates Market to Reach US$ 30.42 Billion by 2033 at 11.2% CAGR …
According to DataM Intelligence, the global antibody-drug conjugates (ADC) market reached US$ 11.96 billion in 2024 and is expected to reach US$ 30.42 billion by 2033, growing at a CAGR of 11.2% during the forecast period 2025-2033. Market growth is strongly driven by the rising global cancer burden, increasing adoption of targeted oncology therapies, advances in linker and payload technologies, and strong clinical success of next-generation ADCs in solid tumors…
Cell Dissociation Market to Reach US$ 915.8 Million by 2033 at 8.7% CAGR; Rising …
The Global Cell Dissociation Market reached US$ 430.6 million in 2024 and is expected to reach US$ 915.8 million by 2033, growing at a CAGR of 8.7% during the forecast period 2025-2033. The market is expanding steadily due to increasing demand for cell-based research, rising adoption of stem cell and regenerative medicine therapies, and growing investment in biotechnology and pharmaceutical R&D. The surge in cancer research, immunotherapy development, and personalized…
Food Waste Management Market to Reach US$ 136.2 Billion by 2032, Driven by Susta …
According to DataM Intelligence, the global food waste management market reached US$ 69.8 billion in 2024 and is expected to reach US$ 136.2 billion by 2032, growing at a CAGR of 8.7% during the forecast period 2025-2032. Market growth is driven by rising global food waste volumes, stringent environmental regulations, increasing adoption of circular economy models, and growing investments in sustainable waste processing technologies such as anaerobic digestion and recycling.…
More Releases for Neuropathic
Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Inte …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%;…
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
